CLPT
ClearPoint Neuro, Inc.
Key Financials
Gross Profit
$22.7M
↑ 18.7%
Revenue
$37.0M
↑ 17.8%
Net Income
$-25540000
↓ 35.0%
Operating Income
$-24164000
↓ 22.4%
EPS (Diluted)
$-0.90
↓ 28.6%
Total Assets
$97.7M
↑ 149.4%
Shareholders' Equity
$28.0M
↑ 10.4%
Long-term Debt
$49.1M
↑ 393.3%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 10/2/2026 | View on SEC |
| 4 | 10/2/2026 | View on SEC |
| 4 | 9/3/2026 | View on SEC |
| SCHEDULE 13G/A | 8/12/2026 | View on SEC |
| SCHEDULE 13G/A | 8/4/2026 | View on SEC |
| 10-Q | 8/3/2026 | View on SEC |
| 8-K | 8/3/2026 | View on SEC |
| SCHEDULE 13G/A | 7/27/2026 | View on SEC |
| 4 | 7/6/2026 | View on SEC |
| 4 | 7/6/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | CLPT |
| Company Name | ClearPoint Neuro, Inc. |
| CIK | 1285550 |
| Sector | Surgical & Medical Instruments & Apparatus |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 3841 |
| SIC Description | Surgical & Medical Instruments & Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 9499006833 |